Silver Hill Hospital remains open during the COVID-19 crisis. We have implemented several proactive safety measures for the protection of those on our campus. Learn more.

VIRTUAL GRAND ROUNDS Medication Treatments for Anxiety Disorders: Where We Are and Where We Are Going

Presented by

Amir Garakani, M.D.

Psychiatrist and Director of Education

Silver Hill Hospital

Wednesday, May 12th, 2021

11:30 a.m. – 1:00 p.m.

Live Presentation via Zoom

Register Here!

Anxiety disorders, in particular panic, generalized anxiety and social anxiety disorders, along with specific phobias, are among the most common psychiatric disorders and are a leading cause of disability and work and school absences. Early treatment of anxiety included the use of benzodiazepines along with psychotherapy although the ascent of tricyclic antidepressants, followed by selective serotonin reuptake inhibitors (SSRIs) and serotonin norepinephrine reuptake inhibitors (SNRIs), became the accepted and recommended first-line medications for anxiety disorders. Although medication treatment, along with cognitive behavioral and exposure therapy, are often felt to be sufficient treatments for anxiety, a sizeable portion of patients continue to experience continued anxiety and poor treatment response or intolerance of SSRI or SNRI medications. This is further complicated by high rates of comorbidity of anxiety with depression and bipolar disorders and substance use disorders. While depression and schizophrenia have seen a rise in novel medication approaches, there has been a comparatively smaller amount of research focus on anxiety disorders. The purpose of this lecture is to briefly review the current medication treatments for anxiety disorders and then discuss the state of research on novel pharmacologic approaches to anxiety.

Accreditation Statement: Silver Hill Hospital is accredited by the Massachusetts Medical Society to provide continuing medical education for physicians.

Designation Statement: Silver Hill Hospital designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

This program is pending approval by the National Association of Social Workers, CT